Literature DB >> 8528572

Enhancement by benzodiazepines of the inhibitory effect of adenosine on skeletal neuromuscular transmission.

L C Chiou1, J Y Ling, C C Chang.   

Abstract

1. Interactions of benzodiazepines with adenosine on the neuromuscular transmission were studied in mouse diaphragm preparations. 2. In tubocurarine (0.6-0.8 microM)-partially paralyzed preparations, diazepam (35 microM) and Ro 5-4864 (3-30 microM), a peripheral type benzodiazepine receptor agonist, potentiated the inhibitory effect of adenosine on indirect twitch responses. 3. The central type receptor agonist, clonazepam did not affect the inhibitory effect of adenosine. 4. The peripheral benzodiazepine receptor antagonist, PK11195 (1-10 microM) attenuated the adenosine inhibition and antagonized the potentiation by Ro 5-4864. 5. Ro 5-4864 failed to enhance further the inhibitory effect of adenosine in the presence of dipyridamole, an adenosine uptake inhibitor that also potentiated adenosine inhibition. 6. Neither Ro 5-4864 nor PK 11195 affected the inhibition produced by a stable adenosine analogue, 2-chloroadenosine, which is not a substrate for the adenosine uptake system. 7. Ro 5-4864 did not affect endplate potentials (e.p.ps) in the absence of adenosine, but reduced the amplitude of e.p.ps in the presence of adenosine without affecting miniature e.p.ps. 8. It is suggested that benzodiazepines potentiate the adenosine-effected presynaptic inhibition of neuromuscular transmission by an inhibition of adenosine uptake through activation of peripheral type benzodiazepine receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8528572      PMCID: PMC1909105          DOI: 10.1111/j.1476-5381.1995.tb16675.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

Review 1.  Peripheral type benzodiazepine receptors.

Authors:  A Verma; S H Snyder
Journal:  Annu Rev Pharmacol Toxicol       Date:  1989       Impact factor: 13.820

Review 2.  Drug interactions at the GABA receptor-ionophore complex.

Authors:  R W Olsen
Journal:  Annu Rev Pharmacol Toxicol       Date:  1982       Impact factor: 13.820

3.  Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies.

Authors:  G Le Fur; M L Perrier; N Vaucher; F Imbault; A Flamier; J Benavides; A Uzan; C Renault; M C Dubroeucq; C Guérémy
Journal:  Life Sci       Date:  1983-04-18       Impact factor: 5.037

4.  Possible mechanism of action of diazepam as an adenosine potentiator.

Authors:  H Moritoki; H Fukuda; M Kotani; T Ueyama; Y Ishida; M Takei
Journal:  Eur J Pharmacol       Date:  1985-07-11       Impact factor: 4.432

5.  Is adenosine an endogenous anticonvulsant?

Authors:  M Dragunow; G V Goddard; R Laverty
Journal:  Epilepsia       Date:  1985 Sep-Oct       Impact factor: 5.864

6.  Flunitrazepam binding sites in rat diaphragm. Receptors for direct neuromuscular effects of benzodiazepines?

Authors:  M Wilkinson; D Grovestine; J T Hamilton
Journal:  Can J Physiol Pharmacol       Date:  1982-07       Impact factor: 2.273

7.  On the mechanism by which adenosine receptor activation inhibits the release of acetylcholine from motor nerve endings.

Authors:  E M Silinsky
Journal:  J Physiol       Date:  1984-01       Impact factor: 5.182

8.  Benzodiazepine inhibition of nucleoside transport in human erythrocytes.

Authors:  J R Hammond; S M Jarvis; A R Paterson; A S Clanachan
Journal:  Biochem Pharmacol       Date:  1983-04-01       Impact factor: 5.858

9.  Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. II. In vivo studies.

Authors:  G Le Fur; F Guilloux; P Rufat; J Benavides; A Uzan; C Renault; M C Dubroeucq; C Guérémy
Journal:  Life Sci       Date:  1983-04-18       Impact factor: 5.037

10.  Inhibition by benzodiazepines and beta-carbolines of brief (5 seconds) synaptosomal accumulation of [3H]-adenosine.

Authors:  P F Morgan; T W Stone
Journal:  Biochem Pharmacol       Date:  1986-05-15       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.